{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:01:19Z","timestamp":1791385279255,"version":"4.3.3"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The overexpressed gene MYEOV in multiple myeloma, as an oncogene, has been widely recognized for its high expression levels in various malignant tumors. MYEOV plays a significant role in multiple malignancies, particularly in diseases such as multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer. The presence of the open reading frame of MYEOV in humans and other primates suggests its potential protein-coding capacity, although direct evidence of functional MYEOV protein is currently lacking. The role of MYEOV in various tumors is not limited to its direct effects as an oncogene; it also includes its complex role in tumor cell signaling pathways and its ability to participate in miRNA regulatory networks as a competing endogenous RNA (ceRNA). Studies have shown that MYEOV may affect the expression of cancer-related genes through enhancer activity. This article aims to provide a comprehensive review of the role of MYEOV, its involvement in signaling pathways in tumor cells, and the latest advancements in MYEOV-targeted therapies.<\/jats:p>","DOI":"10.3389\/fonc.2025.1543590","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:52:09Z","timestamp":1749034329000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of MYEOV gene: a review and future directions"],"prefix":"10.3389","volume":"15","author":[{"given":"Yidan","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ershu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jdb11020027","article-title":"The lost and found: unraveling the functions of orphan genes","volume":"11","author":"Fakhar","year":"2023","journal-title":"J Dev Biol"},{"key":"B2","article-title":"Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)","volume":"95","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1294510","article-title":"Evolutionarily conserved enhancer-associated features within the MYEOV locus suggest a regulatory role for this non-coding DNA region in cancer","volume":"12","author":"Davidson","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01443-4","article-title":"MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity","volume":"39","author":"Liang","year":"2020","journal-title":"Erratum in: Oncogene"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v102:6","article-title":"MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer","volume":"102","author":"Janssen","year":"2002","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0378-1119(94)00562-7","article-title":"The involvement of the chromosome 11q13 region in human Malignancies: cyclin D1 and EMS1 are two new candidate oncogenes\u2013a review","volume":"159","author":"Schuuring","year":"1995","journal-title":"Gene"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3892\/or.17.5.1127","article-title":"Rearrangement and expression of myeov and hst in NIH\/3T3 transfectants: a caveat for the interpretation of DNA transfection analyses","volume":"17","author":"Brecht","year":"2007","journal-title":"Oncol Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4759","article-title":"MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32)","volume":"12","author":"Coccaro","year":"2016","journal-title":"Oncol Lett"},{"key":"B9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41388-018-0484-9","article-title":"MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-\u03b2 pathway in NSCLC","volume":"38","author":"Fang","year":"2019","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2152432","DOI":"10.1155\/2023\/2152432","article-title":"Identification of potential key genes and prognostic biomarkers of lung cancer based on bioinformatics","volume":"2023","author":"Cai","year":"2023","journal-title":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1074\/jbc.M511467200","article-title":"Control of MYEOV protein synthesis by upstream open reading frames","volume":"281","author":"de Almeida","year":"2006","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12957-022-02509-1","article-title":"Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes","volume":"20","author":"Jia","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7150\/jca.53208","article-title":"Analysis of methylation-driven genes in pancreatic ductal adenocarcinoma for predicting prognosis","volume":"12","author":"Zhang","year":"2021","journal-title":"J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"146054","DOI":"10.1016\/j.gene.2021.146054","article-title":"Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis","volume":"810","author":"Pan","year":"2022","journal-title":"Gene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.970507","article-title":"An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12885-022-10433-6","article-title":"MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle\/c-Myc\/mTORC1 pathway","volume":"23","author":"Tange","year":"2023","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C","article-title":"Characterization of 21 newly established esophageal cancer cell lines","volume":"69","author":"Shimada","year":"1992","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s100380200065","article-title":"MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas","volume":"47","author":"Janssen","year":"2002","journal-title":"J Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13237-021-00367-y","article-title":"DNA methylation and regulation of gene expression: Guardian of our health","volume":"64","author":"Dhar","year":"2021","journal-title":"Nucleus (Calcutta)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"984706","DOI":"10.1155\/2015\/984706","article-title":"Adaptive evolution coupled with retrotransposon exaptation allowed for the generation of a human-protein-specific coding gene that promotes cancer cell proliferation and metastasis in both haematological Malignancies and solid tumours: the extraordinary case of MYEOV gene","volume":"2015","author":"Papamichos","year":"2015","journal-title":"Scientifica (Cairo)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac439","article-title":"Computational methods to explore chromatin state dynamics","author":"Orouji","year":"2022","journal-title":"Brief Bioinform"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature12787","article-title":"An atlas of active enhancers across human cell types and tissues","volume":"507","author":"Andersson","year":"2014","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04877-w","article-title":"Compatibility rules of human enhancer and promoter sequences","volume":"607","author":"Bergman","year":"2022","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0191","article-title":"Integrative CAGE and DNA methylation profiling identify epigenetically regulated genes in NSCLC","volume":"15","author":"Horie","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"145337","DOI":"10.1016\/j.gene.2020.145337","article-title":"High expression of MYEOV reflects poor prognosis in non-small cell lung cancer","volume":"770","author":"Zhang","year":"2021","journal-title":"Gene"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603054","article-title":"Net1 and Myeov: computationally identified mediators of gastric cancer","volume":"94","author":"Leyden","year":"2006","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00836-3","article-title":"Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer","volume":"46","author":"Chen","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/jca.89665","article-title":"Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma","volume":"15","author":"Zhou","year":"2024","journal-title":"J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5549298","DOI":"10.1155\/2021\/5549298","article-title":"Bioinformatic analysis of prognostic and immune-related genes in pancreatic cancer","author":"Li","year":"2021","journal-title":"2021"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203846","article-title":"Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma","volume":"14","author":"Wu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215439","article-title":"Identification of MYEOV-associated gene network as a potential therapeutic target in pancreatic cancer","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2408348","DOI":"10.1155\/2019\/2408348","article-title":"Mining TCGA database for tumor microenvironment-related genes of prognostic value in hepatocellular carcinoma","author":"Deng","year":"2019","journal-title":"2019"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10484-9","article-title":"MYEOV with high frequencies of mutations in head and neck cancers facilitates cancer cell Malignant behaviors","volume":"62","author":"Ou","year":"2024","journal-title":"Biochem Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2011.1094","article-title":"Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma","volume":"39","author":"Sugahara","year":"2011","journal-title":"Int J Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.01995.x","article-title":"Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma","volume":"102","author":"Takita","year":"2011","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22827","article-title":"Genomic coamplification of CDK4\/MDM2\/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients","volume":"59","author":"Amoroso","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12859-022-04657-3","article-title":"Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system","volume":"23","author":"Zhang","year":"2022","journal-title":"BMC Bioinf"},{"key":"B39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1756-9966-29-81","article-title":"MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2","volume":"29","author":"Lawlor","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.04.094","article-title":"ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion","volume":"345","author":"Moss","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2020.1757243","article-title":"Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"19","author":"Tang","year":"2020","journal-title":"Cell Cycle"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.exphem.2010.09.002","article-title":"MYEOV is a prognostic factor in multiple myeloma","volume":"38","author":"Moreaux","year":"2010","journal-title":"Exp Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12864-021-08137-5","article-title":"Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma","volume":"22","author":"Wu","year":"2021","journal-title":"BMC Genomics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/cas.v113.3","article-title":"Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1","volume":"113","author":"Oshima","year":"2022","journal-title":"Cancer Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242263","article-title":"Identification of prognostic genes in uveal melanoma microenvironment","volume":"15","author":"Luo","year":"2020","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032841","article-title":"Epigenetic regulation of corneal epithelial differentiation by TET2","volume":"24","author":"Sasamoto","year":"2023"},{"key":"B47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12610-025-00256-3","article-title":"Zinner syndrome: report of a case and whole exome sequencing","volume":"35","author":"He","year":"2025","journal-title":"Basic Clin Androl"},{"key":"B48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00109-006-0136-3","article-title":"A novel locus for autosomal recessive nonsyndromic hearing impairment, DFNB63, maps to chromosome 11q13.2-q13.4","volume":"85","author":"Kalay","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0057-6","article-title":"Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE","volume":"42","author":"Osman","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-019-00302-z","article-title":"MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV","volume":"33","author":"Wang","year":"2020","journal-title":"Hum Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"216811","DOI":"10.1016\/j.canlet.2024.216811","article-title":"Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma","volume":"589","author":"Luo","year":"2024","journal-title":"Cancer Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3821055","DOI":"10.1155\/2021\/3821055","article-title":"Identifying and validating an acidosis-related signature associated with prognosis and tumor immune infiltration characteristics in pancreatic carcinoma","author":"Tang","year":"2021","journal-title":"2021"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010028","article-title":"Metabolic reprogramming of cancer cells during tumor progression and metastasis","volume":"11","author":"Ohshima","year":"2021","journal-title":"Metabolites"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21037\/atm-21-6942","article-title":"The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review","volume":"10","author":"Liu","year":"2022","journal-title":"Ann Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70271","article-title":"HHLA3 silencing suppresses KRAS-mutant non-small-cell lung cancer cell progression through triggering MYEOV-mediated ferroptosis","volume":"39","author":"Tang","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"nzaa153","DOI":"10.1093\/cdn\/nzaa153","article-title":"The roles of mitochondrial folate metabolism in supporting mitochondrial DNA synthesis, oxidative phosphorylation, and cellular function","volume":"4","author":"Xiu","year":"2020","journal-title":"Curr Dev Nutr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.v234.5","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J Cell Physiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41419-021-04387-z","article-title":"The MYEOV-MYC association promotes oncogenic miR-17\/93-5p expression in pancreatic ductal adenocarcinoma","volume":"13","author":"Shen","year":"2021","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1100020","article-title":"A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients","volume":"14","author":"Lan","year":"2023","journal-title":"Front Genet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1543590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:52:10Z","timestamp":1749034330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1543590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":61,"alternative-id":["10.3389\/fonc.2025.1543590"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1543590","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1543590"}}